ID   SYMM_HUMAN              Reviewed;         593 AA.
AC   Q96GW9; A0AVC3; Q76E79; Q8IW62; Q8N7N4;
DT   10-JAN-2006, integrated into UniProtKB/Swiss-Prot.
DT   10-JAN-2006, sequence version 2.
DT   12-APR-2017, entry version 128.
DE   RecName: Full=Methionine--tRNA ligase, mitochondrial;
DE            EC=6.1.1.10;
DE   AltName: Full=Methionyl-tRNA synthetase 2;
DE   AltName: Full=Mitochondrial methionyl-tRNA synthetase;
DE            Short=MtMetRS;
DE   Flags: Precursor;
GN   Name=MARS2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RA   Murata H., Takeuchi-Tomita N.;
RT   "Downregulation of mitochondrial translation factors during the
RT   differentiation of HL-60 cells by TPA.";
RL   Submitted (MAR-2003) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Trachea;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
RA   Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
RA   Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
RA   Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
RA   Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
RA   Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
RA   Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
RA   Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
RA   Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
RA   Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
RA   Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
RA   Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
RA   Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
RA   Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
RA   Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
RA   Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
RA   Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
RA   Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
RA   McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
RA   Waterston R.H., Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2
RT   and 4.";
RL   Nature 434:724-731(2005).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain, and Colon;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   ENZYME ACTIVITY, AND BIOPHYSICOCHEMICAL PROPERTIES.
RX   PubMed=15274629; DOI=10.1021/bi049639w;
RA   Spencer A.C., Heck A., Takeuchi N., Watanabe K., Spremulli L.L.;
RT   "Characterization of the human mitochondrial methionyl-tRNA
RT   synthetase.";
RL   Biochemistry 43:9743-9754(2004).
RN   [6]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [7]
RP   INVOLVEMENT IN SPAX3.
RX   PubMed=22448145; DOI=10.1371/journal.pbio.1001288;
RA   Bayat V., Thiffault I., Jaiswal M., Tetreault M., Donti T.,
RA   Sasarman F., Bernard G., Demers-Lamarche J., Dicaire M.J., Mathieu J.,
RA   Vanasse M., Bouchard J.P., Rioux M.F., Lourenco C.M., Li Z.,
RA   Haueter C., Shoubridge E.A., Graham B.H., Brais B., Bellen H.J.;
RT   "Mutations in the mitochondrial methionyl-tRNA synthetase cause a
RT   neurodegenerative phenotype in flies and a recessive ataxia (ARSAL) in
RT   humans.";
RL   PLoS Biol. 10:E1001288-E1001288(2012).
RN   [8]
RP   INVOLVEMENT IN COXPD25, AND VARIANT COXPD25 TRP-142.
RX   PubMed=25754315; DOI=10.1002/humu.22781;
RA   Webb B.D., Wheeler P.G., Hagen J.J., Cohen N., Linderman M.D.,
RA   Diaz G.A., Naidich T.P., Rodenburg R.J., Houten S.M., Schadt E.E.;
RT   "Novel, compound heterozygous, single-nucleotide variants in MARS2
RT   associated with developmental delay, poor growth, and sensorineural
RT   hearing loss.";
RL   Hum. Mutat. 36:587-592(2015).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
CC   -!- CATALYTIC ACTIVITY: ATP + L-methionine + tRNA(Met) = AMP +
CC       diphosphate + L-methionyl-tRNA(Met).
CC       {ECO:0000269|PubMed:15274629}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=18 uM for Met {ECO:0000269|PubMed:15274629};
CC         KM=85 uM for ATP {ECO:0000269|PubMed:15274629};
CC         KM=2.1 uM for tRNA-Met {ECO:0000269|PubMed:15274629};
CC       pH dependence:
CC         Optimum pH is 7.8-8.2. {ECO:0000269|PubMed:15274629};
CC   -!- SUBCELLULAR LOCATION: Mitochondrion matrix {ECO:0000305}.
CC   -!- DISEASE: Spastic ataxia 3, autosomal recessive (SPAX3)
CC       [MIM:611390]: A neurologic disorder characterized by cerebellar
CC       ataxia, ataxic gait, spasticity, and hyperreflexia. Other variable
CC       features include dysarthria, dysmetria, mild cognitive impairment,
CC       urinary urgency and dystonic positioning.
CC       {ECO:0000269|PubMed:22448145}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- DISEASE: Combined oxidative phosphorylation deficiency 25
CC       (COXPD25) [MIM:616430]: A mitochondrial disorder resulting in
CC       developmental delay, growth failure, and sensorineural hearing
CC       loss. {ECO:0000269|PubMed:25754315}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the class-I aminoacyl-tRNA synthetase
CC       family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAH09115.1; Type=Erroneous initiation; Note=Translation N-terminally shortened.; Evidence={ECO:0000305};
CC       Sequence=AAH40934.1; Type=Erroneous initiation; Note=Translation N-terminally shortened.; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AB107013; BAC92749.1; -; mRNA.
DR   EMBL; AK098121; BAC05238.1; -; mRNA.
DR   EMBL; AC073058; AAX93244.1; -; Genomic_DNA.
DR   EMBL; BC009115; AAH09115.1; ALT_INIT; mRNA.
DR   EMBL; BC040934; AAH40934.1; ALT_INIT; mRNA.
DR   EMBL; BC126294; AAI26295.1; -; mRNA.
DR   CCDS; CCDS33358.1; -.
DR   RefSeq; NP_612404.1; NM_138395.3.
DR   UniGene; Hs.744330; -.
DR   ProteinModelPortal; Q96GW9; -.
DR   SMR; Q96GW9; -.
DR   BioGrid; 124988; 12.
DR   STRING; 9606.ENSP00000282276; -.
DR   DrugBank; DB00134; L-Methionine.
DR   iPTMnet; Q96GW9; -.
DR   PhosphoSitePlus; Q96GW9; -.
DR   BioMuta; MARS2; -.
DR   DMDM; 85541638; -.
DR   EPD; Q96GW9; -.
DR   MaxQB; Q96GW9; -.
DR   PaxDb; Q96GW9; -.
DR   PeptideAtlas; Q96GW9; -.
DR   PRIDE; Q96GW9; -.
DR   DNASU; 92935; -.
DR   Ensembl; ENST00000282276; ENSP00000282276; ENSG00000247626.
DR   GeneID; 92935; -.
DR   KEGG; hsa:92935; -.
DR   UCSC; uc002uuq.4; human.
DR   CTD; 92935; -.
DR   DisGeNET; 92935; -.
DR   GeneCards; MARS2; -.
DR   HGNC; HGNC:25133; MARS2.
DR   HPA; HPA035589; -.
DR   HPA; HPA035590; -.
DR   MalaCards; MARS2; -.
DR   MIM; 609728; gene.
DR   MIM; 611390; phenotype.
DR   MIM; 616430; phenotype.
DR   neXtProt; NX_Q96GW9; -.
DR   OpenTargets; ENSG00000247626; -.
DR   Orphanet; 314603; Autosomal recessive spastic ataxia with leukoencephalopathy.
DR   PharmGKB; PA134863396; -.
DR   eggNOG; KOG0436; Eukaryota.
DR   eggNOG; COG0143; LUCA.
DR   GeneTree; ENSGT00550000075136; -.
DR   HOGENOM; HOG000200401; -.
DR   HOVERGEN; HBG080702; -.
DR   InParanoid; Q96GW9; -.
DR   KO; K01874; -.
DR   OMA; TYPAFCT; -.
DR   OrthoDB; EOG091G08H4; -.
DR   PhylomeDB; Q96GW9; -.
DR   TreeFam; TF105709; -.
DR   Reactome; R-HSA-379726; Mitochondrial tRNA aminoacylation.
DR   GenomeRNAi; 92935; -.
DR   PRO; PR:Q96GW9; -.
DR   Proteomes; UP000005640; Chromosome 2.
DR   Bgee; ENSG00000247626; -.
DR   CleanEx; HS_MARS2; -.
DR   Genevisible; Q96GW9; HS.
DR   GO; GO:0005759; C:mitochondrial matrix; IDA:UniProtKB.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0004825; F:methionine-tRNA ligase activity; IDA:UniProtKB.
DR   GO; GO:0006431; P:methionyl-tRNA aminoacylation; IDA:UniProtKB.
DR   GO; GO:0006418; P:tRNA aminoacylation for protein translation; TAS:Reactome.
DR   CDD; cd00814; MetRS_core; 1.
DR   Gene3D; 1.10.730.10; -; 1.
DR   Gene3D; 3.40.50.620; -; 2.
DR   InterPro; IPR014758; Met-tRNA_synth.
DR   InterPro; IPR015413; Methionyl/Leucyl_tRNA_Synth.
DR   InterPro; IPR033911; MetRS_core.
DR   InterPro; IPR014729; Rossmann-like_a/b/a_fold.
DR   InterPro; IPR009080; tRNAsynth_Ia_anticodon-bd.
DR   Pfam; PF09334; tRNA-synt_1g; 1.
DR   PRINTS; PR01041; TRNASYNTHMET.
DR   SUPFAM; SSF47323; SSF47323; 1.
DR   TIGRFAMs; TIGR00398; metG; 1.
PE   1: Evidence at protein level;
KW   Aminoacyl-tRNA synthetase; ATP-binding; Complete proteome; Deafness;
KW   Disease mutation; Ligase; Mitochondrion; Neurodegeneration;
KW   Nucleotide-binding; Protein biosynthesis; Reference proteome;
KW   Transit peptide.
FT   TRANSIT       1     29       Mitochondrion. {ECO:0000255}.
FT   CHAIN        30    593       Methionine--tRNA ligase, mitochondrial.
FT                                /FTId=PRO_0000045493.
FT   MOTIF        52     62       "HIGH" region.
FT   MOTIF       347    351       "KMSKS" region.
FT   BINDING     350    350       ATP. {ECO:0000250}.
FT   VARIANT     142    142       R -> W (in COXPD25; dbSNP:rs794726870).
FT                                {ECO:0000269|PubMed:25754315}.
FT                                /FTId=VAR_073858.
FT   CONFLICT    535    536       LL -> MM (in Ref. 1; BAC92749).
FT                                {ECO:0000305}.
SQ   SEQUENCE   593 AA;  66591 MW;  A5076FD9F31F4B96 CRC64;
     MLRTSVLRLL GRTGASRLSL LEDFGPRYYS SGSLSAGDDA CDVRAYFTTP IFYVNAAPHI
     GHLYSALLAD ALCRHRRLRG PSTAATRFST GTDEHGLKIQ QAAATAGLAP TELCDRVSEQ
     FQQLFQEAGI SCTDFIRTTE ARHRVAVQHF WGVLKSRGLL YKGVYEGWYC ASDECFLPEA
     KVTQQPGPSG DSFPVSLESG HPVSWTKEEN YIFRLSQFRK PLQRWLRGNP QAITPEPFHH
     VVLQWLDEEL PDLSVSRRSS HLHWGIPVPG DDSQTIYVWL DALVNYLTVI GYPNAEFKSW
     WPATSHIIGK DILKFHAIYW PAFLLGAGMS PPQRICVHSH WTVCGQKMSK SLGNVVDPRT
     CLNRYTVDGF RYFLLRQGVP NWDCDYYDEK VVKLLNSELA DALGGLLNRC TAKRINPSET
     YPAFCTTCFP SEPGLVGPSV RAQAEDYALV SAVATLPKQV ADHYDNFRIY KALEAVSSCV
     RQTNGFVQRH APWKLNWESP VDAPWLGTVL HVALECLRVF GTLLQPVTPS LADKLLSRLG
     VSASERSLGE LYFLPRFYGH PCPFEGRRLG PETGLLFPRL DQSRTWLVKA HRT
//
